| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.02B | +615.5% | -45.4% |
| Cost of Revenue | $207.0M | +73.9% | -59.7% |
| R&D Expense | $801.0M | +14.4% | -29.6% |
| SG&A Expense | $268.0M | +16.5% | -4.6% |
| Operating Income | -$260.0M | +71.3% | -271.4% |
| Pre-tax Income | -$187.0M | +77.1% | -990.5% |
| Income Tax | $13.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.13B | -11.5% | -31.1% |
| Accounts Receivable | $1.05B | +2805.6% | -33.1% |
| Inventory | $332.0M | +38.3% | -19.4% |
| Current Assets | $6.60B | +6.9% | -31.7% |
| Total Assets | $12.13B | +1.0% | -23.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.80B | — | — |
| Capital Expenditures | $153.0M | — | — |
| Investing Cash Flow | $1.99B | — | — |
| Financing Cash Flow | $12.0M | — | — |
| Free Cash Flow | -$2.96B | — | — |
| +85.7% |
| +62.5% |
| Net Income | -$200.0M | +75.8% | -1638.5% |
| EPS (Basic) | -$0.51 | +76.1% | -1800.0% |
| EPS (Diluted) | -$0.51 | +76.1% | -1800.0% |
| $1.68B |
| +6.9% |
| -23.6% |
| Total Liabilities | $2.81B | +7.4% | -27.6% |
| Stockholders' Equity | $9.33B | -0.7% | -21.8% |